January 24 -- China Life celebrated the establishment of its first flagship healthcare private equity fund- the China Life Chengda Healthcare Investment Fund, which is also the first PE fund of insurance companies since China Insurance Regulatory Commission issued the insurance industry PE regulations.
The Fund was established in November 2016 with an initial AUM of RMB12bn, and a total AUM of RMB50bn, which makes it the largest healthcare industry focused fund in China.
Since its establishment in November 2016, this Fund has invested about RMB3bn in several key leading companies in the healthcare industry including GBI, Innovent and Dareway, becoming one of the leading fund focused on healthcare industry in China.
“China Life Private Equity Investment Company is determined to make the healthcare fund one of the leading professional investment vehicle in the healthcare market, and build up the ecology linking insurance, medical service and healthcare management, serving millions of China Life’s insurance policy holders,” said Wan Yiqing, CEO of China Life Private Equity Investment Company, the manager of the healthcare fund.
China Life is the largest life insurance provider in China with combined total assets of RMB3.36 trillion as at the end of 2016.
Miu Jianmin, CEO of China Life Group
Zhang Fengming, CEO of China Life Investment Holding Company Limited
Wan Yiqing, CEO of China Life Private Equity Investment Company